NCT00184353

Brief Summary

Increasing magnetic field is known to give improvements in signal-to-noise-ratio (SNR) and spectral resolution. To investigate this, spectra from different subjects were examined using two clinical MR instruments operating at 1.5T and 3T respectively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2003

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2003

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2004

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2005

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 13, 2005

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 16, 2005

Completed
Last Updated

October 21, 2011

Status Verified

October 1, 2011

Enrollment Period

1.1 years

First QC Date

September 13, 2005

Last Update Submit

October 20, 2011

Conditions

Neoplasm Metastases

Keywords

brain metastasissignal to noise ratiospectral resolution

Study Arms (2)

brain metastases

6 patients

healthy

13 volunteers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with brain metastases

You may qualify if:

  • brain metastases

You may not qualify if:

  • children
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Norwegian University of Science and Technology

Trondheim, N-7489, Norway

Location

Related Publications (1)

  • Sjobakk TE, Lundgren S, Kristoffersen A, Singstad T, Svarliaunet AJ, Sonnewald U, Gribbestad IS. Clinical 1H magnetic resonance spectroscopy of brain metastases at 1.5T and 3T. Acta Radiol. 2006 Jun;47(5):501-8. doi: 10.1080/02841850600644808.

    PMID: 16796315RESULT

MeSH Terms

Conditions

Neoplasm MetastasisBrain Neoplasms

Condition Hierarchy (Ancestors)

Neoplastic ProcessesNeoplasmsPathologic ProcessesPathological Conditions, Signs and SymptomsCentral Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Steinar Lundgren, MD PhD

    Cancer Clinic, St.Olavs Hospital Trondheim University Hospital

    STUDY DIRECTOR

  • Ingrid S Gribbestad, PhD

    Norwegian University of Science and Technology, Faculty of Medicine

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2005

First Posted

September 16, 2005

Study Start

November 1, 2003

Primary Completion

December 1, 2004

Study Completion

June 1, 2005

Last Updated

October 21, 2011

Record last verified: 2011-10

Locations

NO(1)